Lexaria Bioscience Corp

Lexaria Bioscience Corp operates as a biotechnology company It develops and outlicenses its patented drug delivery technology DehydraTECH which combines lipophilic molecules or active pharmaceutical ingredients with specific longchain fatty acids and carrier compounds that improve the way they enter the bloodstream increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods The companys DehydraTECH is used with a range of active molecules encompassing fatsoluble vitamins pain medications hormones PDE5 inhibitors antivirals oral nicotine and its analogs and cannabinoids Its DehydraTECH technology evaluates therapeutic indications including hypertension heart disease and diabetes and is suitable for a variety of product formats such as pharmaceuticals nutraceuticals over the counter and consumer packaged goods Lexaria Bioscience Corp was incorporated in 2004 and is headquartered in Kelowna Canada